FUNDAMANT: an interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimer’s disease

por Novak, Petr, Schmidt, Reinhold, Kontsekova, Eva, Kovacech, Branislav, Smolek, Tomas, Katina, Stanislav, Fialova, Lubica, Prcina, Michal, Parrak, Vojtech, Dal-Bianco, Peter, Brunner, Martin, Staffen, Wolfgang, Rainer, Michael, Ondrus, Matej, Ropele, Stefan, Smisek, Miroslav, Sivak, Roman, Zilka, Norbert, Winblad, Bengt, Novak, Michal
Publicado 2018

Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System

por van Eimeren, Thilo, Antonini, Angelo, Berg, Daniela, Bohnen, Nico, Ceravolo, Roberto, Drzezga, Alexander, Höglinger, Günter U., Higuchi, Makoto, Lehericy, Stephane, Lewis, Simon, Monchi, Oury, Nestor, Peter, Ondrus, Matej, Pavese, Nicola, Peralta, María Cecilia, Piccini, Paola, Pineda-Pardo, José Ángel, Rektorová, Irena, Rodríguez-Oroz, María, Rominger, Axel, Seppi, Klaus, Stoessl, A. Jon, Tessitore, Alessandro, Thobois, Stephane, Kaasinen, Valtteri, Wenning, Gregor, Siebner, Hartwig R., Strafella, Antonio P., Rowe, James B.
Publicado 2019